Associate Director, DMPK

Brisbane, California
Oct 11, 2021
Biotech Bay
Required Education
Position Type
Full time
About QED Therapeutics & BridgeBio Pharma

QED Therapeutics, an affiliate of BridgeBio Pharma, focuses on precision medicine for FGFR-driven cancers and diseases. The company’s first therapy, TRUSELTIQTM (infigratinib), is an orally administered FGFR1-3 tyrosine kinase inhibitor that the US FDA recently approved to treat patients with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement. We are also evaluating infigratinib for the treatment of other FGFR-driven cancers and the treatment of achondroplasia and other skeletal dysplasias.

QED is derived from the Latin “Quod Erat Demonstrandum” —Thus; It Has Been Proven. Our business is inspired by our values:






FGFR=fibroblast growth factor receptor.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, Boston, New York, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zug, Switzerland, and are expanding across Europe.

To learn more about our story and company culture, visit us at |

Who You Are:

This is an exciting opportunity for an experienced DMPK leader to design and execute DMPK strategies to support clinical development programs, including the study design, protocol review, overseeing study execution, data analyses, and reporting.  This successful candidate will be a member of cross-functional teams, ensuring that DMPK strategies are appropriately considered and executed timely. This position will report to the VP of Clinical Pharmacology and can be remote.

  • Serve as DMPK lead on cross-functional teams in both early and late-stage projects
  • Design and oversee the execution of DMPK strategies to achieve program objectives
  • Design and outsource in vitro and in vivo ADME, DMPK, PK/PD studies to characterize the lead compound
  • Interprets and presents DMPK scientific data/results to the team
  • Perform PK/PD modeling and assists in clinical study protocol design, data analysis/interpretation, and reporting
  • Write, review and edit relevant sections of regulatory submissions and respond to queries from regulatory agencies
  • No matter your role at BridgeBio, successful team members are:

  • Patient Champions, who put patients first and uphold strict ethical standards
  • Entrepreneurial Operators, who drive towards practical solutions and have an ownership mindset
  • Truth Seekers, who are detailed, rational, and humble problem solvers
  • Individuals Who Inspire Excellence in themselves and those around them
  • High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements:
  • Ph.D. in Pharmaceutical Sciences, or related discipline with a focus on drug metabolism and pharmacokinetics
  • At least six years of industry experience in DMPK focused on small molecules
  • Broad understanding of DMPK and PK/PD concepts and relevant areas such as physicochemical properties, drug-metabolizing enzyme and transporter kinetics, pharmacokinetics, biotransformation, and bioanalytical sciences
  • Experience with modeling and PK/PD analysis
  • Ability to collaborate and effectively lead cross-functionally and in a team setting
  • Excellent interpersonal, verbal, and written communication skills to communicate effectively with external collaborators and internal project teams

What We Offer:
  • Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
  • A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
  • An unyielding commitment to always putting patients first. Learn more about how we do this here
  • A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
  • A place where you own the vision – both for your program and your own career path
  • A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
  • Access to learning and development resources to help you get in the best professional shape of your life
  • Robust and market competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
  • Flexible PTO
  • Rapid career advancement for strong performers
  • Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time
  • Partnerships with leading institutions
  • Commitment to Diversity, Equity & Inclusion – with initiatives like Women at Bridge, we are committed to fostering an inclusive environment where every person feels seen, valued, and heard

We will not accept unsolicited resumes from agencies. Please do not send agency resumes to our website or BridgeBio and affiliating employees.